Historical review from 2026-09-24. Current price and availability are unconfirmed; check the original marketplace.
Insect Bite ID shows exceptional unit economics—$2,524/mo revenue, near-100% profit margins, and a 2.48x multiple—but scores below the acquisition threshold due to critical missing traction data. The listing does not disclose customer count, user retention, churn, growth trajectory, or revenue history. Without evidence of paying customer durability, organic acquisition channels, or sustained demand, the business appears early-stage despite strong margins. A buyer would be acquiring software margins without visibility into customer stickiness or repeatable growth mechanics.
While the software itself—image classification, confidence scoring, and bite-tracking UI—is reproducible within 4–6 weeks using modern AI APIs (Claude Vision, OpenAI GPT-4V) and a basic mobile/web stack, the listing provides no evidence of established customer acquisition, network effects, or durable revenue streams. The nearly 100% margin reflects low operational cost, not proven business traction. Without disclosed customer count, retention data, organic growth channels, or evidence of sustained demand, purchasing $75K for verified revenue without durability proof is riskier than building an MVP in parallel. The software asset is lightweight; the business asset—paying, retained customers—is unverified.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Snap a photo to identify insect bites in seconds with AI. Get confidence scores, bite care advice, and track bites over time for extra peace of mind.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.